IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 7524 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded106    
    Comments [Add]    

Recommend this journal


Year : 1991  |  Volume : 23  |  Issue : 2  |  Page : 75-80

Desferrioxamine treatment in aluminium overload patients : An aluminium binding study

Correspondence Address:
A A Moshtaghie

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

1. The binding of aluminium to serum proteins was investigated using immuno-affinity chromatography technique. Anti-transferrin coupled to CNBr-activated sepharose-4B was used. 2. 82% of the aluminium in the blood circulation was found to be transferrin bound and the remaining was ultrafiltrable. 3. Infusion of desferrioxamine leads to the elevation of plasma aluminium concentration approximately by 225 per cent. 4. It might be concluded that transferrin is the major aluminium carrier protein in the plasma and desferrioxamine may be used in the therapy of aluminium toxicity in aluminium overload patients with chronic renal failure maintained on regular hemodialysis.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow